Dina S El-Agamy1,2, Mohamed A Elkablawy3,4, Hany M Abo-Haded5. 1. Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, P.O. Box 344, Al-Madinah Al-Munawwarah, 30001, Saudi Arabia. dinaagamy1@yahoo.com. 2. Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt. dinaagamy1@yahoo.com. 3. Department of Pathology, College of Medicine, Taibah University, Al-Madinah Al-Munawwarah, 30001, Saudi Arabia. 4. Department of Pathology, Faculty of Medicine, Menoufia University, Menoufia, Egypt. 5. Cardiology Unit, Department of Pediatrics, College of Medicine, Taibah University, Al-Madinah Al-Munawwarah, 30001, Saudi Arabia.
Abstract
PURPOSE: Cyclophosphamide (CP) is a frequently used anticancer and immunosuppressant although its use has been associated with severe cardiotoxicity. The present study examined the ability of methyl palmitate (MP) to counteract CP-induced cardiotoxicity. METHODS: Adult male Wistar rats were divided into four groups. The first one served as control while the second received a single injection of CP (200 mg/kg, i.p.). The other two groups were administered MP at two different dose levels (300, 400 mg/kg) for 10 days before and 7 days after CP single injection. RESULTS: CP injection resulted in marked cardiac injury as presented by ECG abnormal changes, elevation of serum creatine kinase-MB (CK-MB), cardiac troponin I, troponin T and lactate dehydrogenase (LDH) and enormous histopathological lesions. Moreover, CP-induced oxidative stress as it elevated malondialdehyde (MDA) and diminished superoxide dismutase activity and glutathione content in heart tissue. Additionally, CP-induced overexpression of toll-like receptors-4 (TLR-4) and nuclear factor kappa-B (NF-κB) accompanied by overproduction of inflammatory cytokines (TNF-α, NO). CP activated cardiomyocyte apoptosis as it increased apoptosis parameters (Bax and caspase-3) and decreased anti-apoptotic marker (Bcl-2). On the other hand, MP treatment attenuated all of the measured parameters of CP-induced cardiotoxicity. MP counteracted CP-induced oxidative stress and suppressed TLR-4 and NF-κB overexpression. Also, levels of cytokines and apoptotic markers were declined while Bcl-2 was elevated in MP treated animals. CONCLUSIONS: MP may serve as a new cardioprotective candidate. The cardioprotective effects of MP may be attributed to its ability to suppress oxidative stress and interrupt TLR4/NF-κB signaling pathway with subsequent amelioration of apoptosis.
PURPOSE:Cyclophosphamide (CP) is a frequently used anticancer and immunosuppressant although its use has been associated with severe cardiotoxicity. The present study examined the ability of methyl palmitate (MP) to counteract CP-induced cardiotoxicity. METHODS: Adult male Wistar rats were divided into four groups. The first one served as control while the second received a single injection of CP (200 mg/kg, i.p.). The other two groups were administered MP at two different dose levels (300, 400 mg/kg) for 10 days before and 7 days after CP single injection. RESULTS: CP injection resulted in marked cardiac injury as presented by ECG abnormal changes, elevation of serum creatine kinase-MB (CK-MB), cardiac troponin I, troponin T and lactate dehydrogenase (LDH) and enormous histopathological lesions. Moreover, CP-induced oxidative stress as it elevated malondialdehyde (MDA) and diminished superoxide dismutase activity and glutathione content in heart tissue. Additionally, CP-induced overexpression of toll-like receptors-4 (TLR-4) and nuclear factor kappa-B (NF-κB) accompanied by overproduction of inflammatory cytokines (TNF-α, NO). CP activated cardiomyocyte apoptosis as it increased apoptosis parameters (Bax and caspase-3) and decreased anti-apoptotic marker (Bcl-2). On the other hand, MP treatment attenuated all of the measured parameters of CP-induced cardiotoxicity. MP counteracted CP-induced oxidative stress and suppressed TLR-4 and NF-κB overexpression. Also, levels of cytokines and apoptotic markers were declined while Bcl-2 was elevated in MP treated animals. CONCLUSIONS:MP may serve as a new cardioprotective candidate. The cardioprotective effects of MP may be attributed to its ability to suppress oxidative stress and interrupt TLR4/NF-κB signaling pathway with subsequent amelioration of apoptosis.
Authors: Hany M Abo-Haded; Mohamed A Elkablawy; Zeyad Al-Johani; Osama Al-Ahmadi; Dina S El-Agamy Journal: PLoS One Date: 2017-03-23 Impact factor: 3.240
Authors: Heba M I Abdallah; Rehab F Abdel-Rahman; Sally A El Awdan; Rasha M Allam; Aliaa E M K El-Mosallamy; Manal S Selim; Sahar S Mohamed; Mahmoud S Arbid; Abdel Razik H Farrag Journal: Heliyon Date: 2019-05-07
Authors: Ghada A Abdel-Latif; Azza H Abd Elwahab; Rehab A Hasan; Noura F ElMongy; Maggie M Ramzy; Manal L Louka; Mona F Schaalan Journal: Sci Rep Date: 2020-08-03 Impact factor: 4.379